Issue 6/2020
Content (20 Articles)
JSH practical guidelines for hematological malignancies, 2018: I. Leukemia—2. Acute promyelocytic leukemia (APL)
Hiroyuki Fujita, Yuichi Ishikawa, Yasuhisa Yokoyama
Metabolomics analysis identifies lysine and taurine as candidate prognostic biomarkers for AML-M2 patients
Xuan Zhou, Meihong Zheng, Qien Wang, Jiye Aa, Bei Cao, Juan Li
Prediction of response to first-line therapy with ITP by flow cytometric analysis of bone marrow lymphocyte phenotypes
Satoko Oka, Kazuo Ono, Masaharu Nohgawa
Plasma-derived factors VIIa and X mixtures (Byclot®) significantly improve impairment of coagulant potential ex vivo in plasmas from acquired hemophilia A patients
Satoshi Ochi, Masahiro Takeyama, Midori Shima, Keiji Nogami
Establishment of a megakaryoblastic cell line for conventional assessment of platelet calcium signaling
Hiroshi Saito, Morisada Hayakawa, Nobuhiko Kamoshita, Atsushi Yasumoto, Katsue Suzuki-Inoue, Yutaka Yatomi, Tsukasa Ohmori
Comparison of clinical phenotype with genetic and laboratory results in 31 patients with congenital dysfibrinogenemia in northern Slovakia
Tomas Simurda, Jana Zolkova, Zuzana Kolkova, Dusan Loderer, Miroslava Dobrotova, Ingrid Skornova, Monika Brunclíkova, Marian Grendar, Zora Lasabova, Jan Stasko, Peter Kubisz
A retrospective analysis of treatment outcomes in 45 patients with cardiac light-chain amyloidosis: a single-center experience in Japan
Shin-ichi Fuchida, Daisuke Ide, Yoko Taminishi-Katsuragawa, Takaomi Suga, Saori Matsui-Maegawa, Naoki Maruyama, Yumi Iwamura, Yohei Kitamura, Yoshifumi Okawa, Akira Okano, Mayumi Hatsuse, Satoshi Murakami, Chihiro Shimazaki
Treatment outcomes of chronic-phase chronic myeloid leukemia with resistance and/or intolerance to a 1st-line tyrosine kinase inhibitor in Japan: the results of the New TARGET study 2nd-line
Masatoshi Sakurai, Shinichiro Okamoto, Itaru Matsumura, Satsuki Murakami, Makiko Takizawa, Masato Waki, Daiki Hirano, Reiko Watanabe-Nakaseko, Naoki Kobayashi, Masaki Iino, Hideki Mitsui, Yuichi Ishikawa, Naoto Takahashi, Tatsuya Kawaguchi, Ritsuro Suzuki, Kazuhito Yamamoto, Masahiro Kizaki, Kazunori Ohnishi, Tomoki Naoe, Koichi Akashi
Influence of proton pump inhibitors and H2-receptor antagonists on the efficacy and safety of dasatinib in chronic myeloid leukemia patients
Yoshimichi Koutake, Jun Taniguchi, Naoko Yasumori, Hiroki Nagaishi, Tomoaki Eto, Kotaro Nakashima, Mami Fukazawa, Toshinobu Hayashi
Clinical significance of autologous blood transfusions in bone marrow harvest from unrelated donors
Shin-ichiro Fujiwara, Kazuhiko Ikeda, Shuichi Kino, Asashi Tanaka, Yuichi Hasegawa, Keizo Fujino, Shigeyoshi Makino, Mayumi Matsumoto, Akihiko Yokohama, Akihiro Takeshita, Kazuo Muroi
Health-related quality of life in peripheral blood stem cell donors and bone marrow donors: a prospective study in Japan
Ayumi Fujimoto, Ritsuro Suzuki, Katsumi Orihara, Minako Iida, Takuya Yamashita, Koji Nagafuji, Heiwa Kanamori, Yoshihisa Kodera, Koichi Miyamura, Shinichiro Okamoto, Masayuki Hino
LMP1-specific cytotoxic T cells for the treatment of EBV-related post-transplantation lymphoproliferative disorders
Jian Hong, Jing Ni, Min Ruan, Mingzhen Yang, Qianggang Dong, Qingsheng Li
Clinical outcomes of persistent colonization with multidrug-resistant Gram-negative rods in adult patients undergoing single cord blood transplantation
Mai Mizusawa, Takaaki Konuma, Seiko Kato, Masamichi Isobe, Hiroko Shibata, Masato Suzuki, Osamu Takahashi, Maki Oiwa-Monna, Satoshi Takahashi, Arinobu Tojo
Impact of graft-versus-host disease on the clinical outcome of allogeneic hematopoietic stem cell transplantation for non-malignant diseases
Katsutsugu Umeda, Kohsuke Imai, Masakatsu Yanagimachi, Hiromasa Yabe, Masao Kobayashi, Yoshiyuki Takahashi, Michiko Kajiwara, Nao Yoshida, Yuko Cho, Masami Inoue, Yoshiko Hashii, Yoshiko Atsuta, Tomohiro Morio
Nitrosourea, etoposide and cyclophosphamide followed by autologous stem cell transplantation for pediatric lymphoma patients
Jung Yoon Choi, Hyoung Jin Kang, Hong Yul An, Kyung Taek Hong, Hee Young Shin
Hemophagocytic relapsed intramedullary plasmacytoma
Tarek H. Mouhieddine, Bart Barlogie, Julie Teruya-Feldstein
Immunophenotypic analysis of cerebrospinal fluid reveals concurrent development of ATL in the CNS of a HAM/TSP patient
Reina Takeda, Tomohiro Ishigaki, Nobuhiro Ohno, Kazuaki Yokoyama, Toyotaka Kawamata, Tomofusa Fukuyama, Natsumi Araya, Yoshihisa Yamano, Kaoru Uchimaru, Arinobu Tojo
Immune dysregulation syndrome with de novo CTLA4 germline mutation responsive to abatacept therapy
Hiroshi Ureshino, Shuichi Koarada, Kazuharu Kamachi, Mariko Yoshimura, Masako Yokoo, Yasushi Kubota, Toshihiko Ando, Tatsuo Ichinohe, Tomohiro Morio, Shinya Kimura
Does patient sex play a role in treatment-free remission in chronic myeloid leukemia?
Hiroshi Ureshino, Kazuharu Kamachi, Shinya Kimura
No sex-related difference in achievement of treatment-free remission following treatment with tyrosine kinase inhibitors in chronic myeloid leukemia
Hiroki Yamaguchi, Koiti Inokuchi